NHS leaders have warned that the cost of supporting people with ADHD and autism is becoming “out of control,” adding a fresh financial and operational strain to a health service already under pressure. The warning comes as recent reporting in The BMJ highlights growing concern about how the NHS is coping with demand for neurodevelopmental assessments, follow-up care and wider support services.
Cost pressures add to a crowded NHS agenda
The BMJ’s latest news coverage on September 1, 2026, placed the issue among a cluster of stories showing how routine care, specialist services and system-wide capacity are all being stretched at the same time. In the same news feed, the publication also reported on record spending linked to paper records, vaccination trends and other care-related developments, underscoring the breadth of challenges facing the health service.
The warning over ADHD and autism spending reflects a broader debate about how NHS resources should be allocated when demand is increasing across several parts of the system. While the latest BMJ item did not provide a detailed breakdown of the financial figures in the headline listing, it signalled that senior leaders see the issue as urgent and unresolved.
What the latest reports show
Recent BMJ reporting also highlighted the continuing reliance on paper in parts of the NHS, with costs rising as hospitals still depend on manual record keeping. That story points to a service where legacy systems and modern demand are colliding, creating extra pressure on staff and budgets.
Elsewhere in the same news cycle, BMJ reported that UK childhood vaccination rates fell in babies but stabilised at age 5, while other items focused on clinical and regulatory issues such as an AI-assisted brain tumour surgery and a tribunal involving a doctor who removed patients’ ovaries without consent. Taken together, the news agenda suggests that NHS leaders are dealing with a mix of workforce, access, governance and funding challenges rather than a single isolated problem.
A wider question for service planning
The latest warnings over ADHD and autism costs are likely to feed into longer-running arguments about referral pathways, diagnostic capacity and the level of support available after diagnosis. Even without a full financial statement in the headline listing, the fact that NHS leaders are publicly describing the situation in such stark terms indicates that the issue is now central to service planning discussions.
For the NHS, the immediate challenge is balancing rising demand in neurodevelopmental care with other urgent priorities already competing for attention. The latest BMJ coverage suggests that, unless resources and pathways are adjusted, cost pressures in this area could continue to grow.
Photo source: AI-generated or edited image
